BRIGHT-SC: Blisibimod Response in IgA Nephropathy Following At-Home Treatment by Subcutaneous Administration
Clinical trial NCT02062684 · COMPLETED
Trial details
- NCT number
- NCT02062684
- Sponsor
- Anthera Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2017-03-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.